<--- Back to Details
First PageDocument Content
Health / MedDRA / Pharmaceutical sciences / Pharmaceuticals policy / Psychopathology / EudraVigilance / Pharmacovigilance / Mental disorder / Immune system / Pharmacology / Medicine / Drug safety
Date: 2014-09-23 12:14:27
Health
MedDRA
Pharmaceutical sciences
Pharmaceuticals policy
Psychopathology
EudraVigilance
Pharmacovigilance
Mental disorder
Immune system
Pharmacology
Medicine
Drug safety

Microsoft PowerPoint[removed]Intro_Data_Analysis_SMQs_Physicians.pptx

Add to Reading List

Source URL: www.meddra.org

Download Document from Source Website

File Size: 2,33 MB

Share Document on Facebook

Similar Documents

Microsoft Word - Simple guide to Veterinary Pharmacovigilance in the EU

DocID: 1uY7F - View Document

Pharmaceuticals policy / Health / Medical research / Pharmacovigilance / European Medicines Agency / EudraLex / European Directive on Traditional Herbal Medicinal Products / Postmarketing surveillance / Adverse effect / Qualified Person Responsible For Pharmacovigilance / EudraVigilance

COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10 December 2008 SECVolume I

DocID: 1qH6O - View Document

Pharmaceuticals policy / Medical research / Health / European Medicines Agency / Pharmacovigilance / Qualified Person Responsible For Pharmacovigilance / EudraVigilance

Better vigilance for health health protection protection and and innovation

DocID: 1q6Mb - View Document

Health / Pharmaceuticals policy / Medical research / Drug safety / Clinical research / Clinical trials / Healthcare quality / Pharmacovigilance / EudraVigilance / European Medicines Agency / Adverse effect / VigiBase

Pharmacovigilance: Information systems and services Supporting business activities of the revised pharmacovigilance

DocID: 1q4D4 - View Document

Clinical research / Pharmaceuticals policy / Drug discovery / Clinical trials / Drug safety / Pharmacovigilance / European Medicines Agency / EudraCT / Clinical Trials Directive / Gene therapy / Clinical / EudraVigilance

EU Clinical Trials Register Disclaimer: The explanations are provided for the benefit of public users of the system and to enhance general understanding of terms used. They are not intended as the regulatory definitions

DocID: 1p4Xj - View Document